Phase 4 N=38 Diagnostic

Study of Arm and Putter Movement in Golfers With Golfer's Cramp

Occupational; Cramp(s)

Bottom Line

View on ClinicalTrials.gov: NCT02032758 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Jul 2016

Primary outcome: Primary: Mean Dynamic Change of Rotation at Impact — -38.4; -32.5; -36.5; NA degrees/sec

Study Design & Population

Study type: Interventional
Phase: Phase 4
Interventions: Propranolol (Drug); Opal Device (Device); Science and Motion PuttLab (SAM) (Procedure); Surface Electromyography EMG (Device)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: Mayo Clinic
Primary completion: Jan 2015

Outcome Measures

Outcome	Result	p-value
PRIMARY Mean Dynamic Change of Rotation at Impact	-38.4; -32.5; -36.5; NA	—
SECONDARY Mean Total Putter Face Rotation Before Impact	3.3; 3.1; 3.4; NA	—

Summary

The investigators will investigate golfers with visual evidence of an involuntary movement while putting before and after treatment with a low dose of propranolol.

Eligibility Criteria

Inclusion criteria

Age 18-75
Complaint of golfer's cramp/yips
Visual evidence of a movement disorder during putting
Able to complete 80 putts during the session

Exclusion criteria

Contraindication to treatment with propranolol
Movement disorder not when putting

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02032758). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.